303 related articles for article (PubMed ID: 35644292)
1. Vaginosis: Advances in new therapeutic development and microbiome restoration.
Mohankumar B; Shandil RK; Narayanan S; Krishnan UM
Microb Pathog; 2022 Jul; 168():105606. PubMed ID: 35644292
[TBL] [Abstract][Full Text] [Related]
2. Correlation Analysis of Vaginal Microbiome Changes and Bacterial Vaginosis Plus Vulvovaginal Candidiasis Mixed Vaginitis Prognosis.
Xiao B; A D; Qin H; Mi L; Zhang D
Front Cell Infect Microbiol; 2022; 12():860589. PubMed ID: 35372135
[TBL] [Abstract][Full Text] [Related]
3. Vaginal microbiota of asymptomatic bacterial vaginosis and vulvovaginal candidiasis: Are they different from normal microbiota?
Pramanick R; Mayadeo N; Warke H; Begum S; Aich P; Aranha C
Microb Pathog; 2019 Sep; 134():103599. PubMed ID: 31212037
[TBL] [Abstract][Full Text] [Related]
4. The urinary microbiota of men and women and its changes in women during bacterial vaginosis and antibiotic treatment.
Gottschick C; Deng ZL; Vital M; Masur C; Abels C; Pieper DH; Wagner-Döbler I
Microbiome; 2017 Aug; 5(1):99. PubMed ID: 28807017
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the vaginal microflora in health and disease.
Datcu R
Dan Med J; 2014 Apr; 61(4):B4830. PubMed ID: 24814599
[TBL] [Abstract][Full Text] [Related]
6. Bacterial Vaginosis: What Do We Currently Know?
Abou Chacra L; Fenollar F; Diop K
Front Cell Infect Microbiol; 2021; 11():672429. PubMed ID: 35118003
[TBL] [Abstract][Full Text] [Related]
7. Treatment of biofilms in bacterial vaginosis by an amphoteric tenside pessary-clinical study and microbiota analysis.
Gottschick C; Deng ZL; Vital M; Masur C; Abels C; Pieper DH; Rohde M; Mendling W; Wagner-Döbler I
Microbiome; 2017 Sep; 5(1):119. PubMed ID: 28903767
[TBL] [Abstract][Full Text] [Related]
8. The Female Vaginal Microbiome in Health and Bacterial Vaginosis.
Chen X; Lu Y; Chen T; Li R
Front Cell Infect Microbiol; 2021; 11():631972. PubMed ID: 33898328
[TBL] [Abstract][Full Text] [Related]
9. Microbiota in vaginal health and pathogenesis of recurrent vulvovaginal infections: a critical review.
Kalia N; Singh J; Kaur M
Ann Clin Microbiol Antimicrob; 2020 Jan; 19(1):5. PubMed ID: 31992328
[TBL] [Abstract][Full Text] [Related]
10. Diverse vaginal microbiomes in reproductive-age women with vulvovaginal candidiasis.
Liu MB; Xu SR; He Y; Deng GH; Sheng HF; Huang XM; Ouyang CY; Zhou HW
PLoS One; 2013; 8(11):e79812. PubMed ID: 24265786
[TBL] [Abstract][Full Text] [Related]
11. An update on the role of Atopobium vaginae in bacterial vaginosis: what to consider when choosing a treatment? A mini review.
Mendling W; Palmeira-de-Oliveira A; Biber S; Prasauskas V
Arch Gynecol Obstet; 2019 Jul; 300(1):1-6. PubMed ID: 30953190
[TBL] [Abstract][Full Text] [Related]
12. Metagenomic Shotgun Sequencing of Endocervical, Vaginal, and Rectal Samples among Fijian Women with and without Chlamydia trachomatis Reveals Disparate Microbial Populations and Function across Anatomic Sites: a Pilot Study.
Bommana S; Richards G; Kama M; Kodimerla R; Jijakli K; Read TD; Dean D
Microbiol Spectr; 2022 Jun; 10(3):e0010522. PubMed ID: 35579443
[TBL] [Abstract][Full Text] [Related]
13. Metatranscriptome Analysis of the Vaginal Microbiota Reveals Potential Mechanisms for Protection against Metronidazole in Bacterial Vaginosis.
Deng ZL; Gottschick C; Bhuju S; Masur C; Abels C; Wagner-Döbler I
mSphere; 2018 Jun; 3(3):. PubMed ID: 29875146
[TBL] [Abstract][Full Text] [Related]
14. [The bacterial vaginosis--treatment problems].
Romanik MK; Ekiel AM; Tomana L; Martirosian G
Wiad Lek; 2007; 60(1-2):64-7. PubMed ID: 17607971
[TBL] [Abstract][Full Text] [Related]
15. The Natural Antimicrobial Subtilosin A Synergizes with Lauramide Arginine Ethyl Ester (LAE), ε-Poly-L-lysine (Polylysine), Clindamycin Phosphate and Metronidazole, Against the Vaginal Pathogen Gardnerella vaginalis.
Cavera VL; Volski A; Chikindas ML
Probiotics Antimicrob Proteins; 2015 Jun; 7(2):164-71. PubMed ID: 25588687
[TBL] [Abstract][Full Text] [Related]
16. Recurrent bacterial vaginosis following metronidazole treatment is associated with microbiota richness at diagnosis.
Gustin AT; Thurman AR; Chandra N; Schifanella L; Alcaide M; Fichorova R; Doncel GF; Gale M; Klatt NR
Am J Obstet Gynecol; 2022 Feb; 226(2):225.e1-225.e15. PubMed ID: 34560047
[TBL] [Abstract][Full Text] [Related]
17. Quantification of Gardnerella vaginalis, Atopobium vaginae and Lactobacillus spp. in bacterial vaginosis.
Numanovic N; Ribis S; Cukic J; Nenadic D; Zivanovic A; Sazdanovic P; Ninkovic V; Baskic D
J Infect Dev Ctries; 2021 Sep; 15(9):1293-1298. PubMed ID: 34669599
[TBL] [Abstract][Full Text] [Related]
18. Gardnerella and vaginal health: the truth is out there.
Rosca AS; Castro J; Sousa LGV; Cerca N
FEMS Microbiol Rev; 2020 Jan; 44(1):73-105. PubMed ID: 31697363
[TBL] [Abstract][Full Text] [Related]
19. Impact of contraceptive initiation on vaginal microbiota.
Achilles SL; Austin MN; Meyn LA; Mhlanga F; Chirenje ZM; Hillier SL
Am J Obstet Gynecol; 2018 Jun; 218(6):622.e1-622.e10. PubMed ID: 29505773
[TBL] [Abstract][Full Text] [Related]
20. Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health.
Chee WJY; Chew SY; Than LTL
Microb Cell Fact; 2020 Nov; 19(1):203. PubMed ID: 33160356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
